These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 21090340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil.
    Chu L, Gu J, Sun L, Qian Q, Qian C, Liu X.
    Gene Ther; 2008 Apr; 15(7):484-94. PubMed ID: 18239605
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
    Ma S, Qu W, Mao L, Zhu Z, Jia L, Zhao L, Zheng X.
    Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.
    Fang L, Cheng Q, Li W, Liu J, Li L, Xu K, Zheng J.
    Virus Res; 2014 Mar 06; 181():61-71. PubMed ID: 24463503
    [Abstract] [Full Text] [Related]

  • 7. Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth.
    Li Y, Zhang B, Zhang H, Zhu X, Feng D, Zhang D, Zhuo B, Li L, Zheng J.
    J Cancer Res Clin Oncol; 2013 Jun 06; 139(6):933-41. PubMed ID: 23443256
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
    Zheng JN, Pei DS, Mao LJ, Liu XY, Mei DD, Zhang BF, Shi Z, Wen RM, Sun XQ.
    Cancer Gene Ther; 2009 Jan 06; 16(1):20-32. PubMed ID: 18690204
    [Abstract] [Full Text] [Related]

  • 9. Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell.
    Liu J, Fang L, Cheng Q, Li L, Su C, Zhang B, Pei D, Yang J, Li W, Zheng J.
    Cancer Sci; 2012 Oct 06; 103(10):1880-8. PubMed ID: 22775978
    [Abstract] [Full Text] [Related]

  • 10. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 06; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene.
    Zheng JN, Pei DS, Sun FH, Zhang BF, Liu XY, Gu JF, Liu YH, Hu XL, Mao LJ, Wen RM, Liu JJ, Li W.
    Cancer Biol Ther; 2009 Jan 06; 8(1):84-91. PubMed ID: 19029834
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Construction of recombinant adenovirus vector by c-myc silencing].
    Wang D, Liu M, Wang M, Zhang Y.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Aug 06; 22(8):969-73. PubMed ID: 18773816
    [Abstract] [Full Text] [Related]

  • 14. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.
    Pan Q, Liu B, Liu J, Cai R, Liu X, Qian C.
    Acta Oncol; 2008 Aug 06; 47(1):135-44. PubMed ID: 17934893
    [Abstract] [Full Text] [Related]

  • 15. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
    Cao X, Yang M, Wei RC, Zeng Y, Gu JF, Huang WD, Yang DQ, Li HL, Ding M, Wei N, Zhang KJ, Xu B, Liu XR, Qian QJ, Liu XY.
    Gene Ther; 2011 Aug 06; 18(8):765-77. PubMed ID: 21412282
    [Abstract] [Full Text] [Related]

  • 16. Prostate cancer-specific and potent antitumor effect of a DD3-controlled oncolytic virus harboring the PTEN gene.
    Ding M, Cao X, Xu HN, Fan JK, Huang HL, Yang DQ, Li YH, Wang J, Li R, Liu XY.
    PLoS One; 2012 Aug 06; 7(4):e35153. PubMed ID: 22509396
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
    Liu X, Cao X, Wei R, Cai Y, Li H, Gui J, Zhong D, Liu XY, Huang K.
    Cancer Gene Ther; 2012 Jan 06; 19(1):49-57. PubMed ID: 21979578
    [Abstract] [Full Text] [Related]

  • 19. VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
    Yoo JY, Kim JH, Kwon YG, Kim EC, Kim NK, Choi HJ, Yun CO.
    Mol Ther; 2007 Feb 06; 15(2):295-302. PubMed ID: 17235307
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.
    Wang F, Wang Z, Tian H, Qi M, Zhai Z, Li S, Li R, Zhang H, Wang W, Fu S, Lu J, Rodriguez R, Guo Y, Zhou L.
    Curr Gene Ther; 2012 Apr 01; 12(2):67-76. PubMed ID: 22384806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.